D
uring thymocyte development in normal mice, rearrangement and expression of the TCR[3 chain gene precedes that of the a chain (1) . The first TCR[3 gene rearrangements are detectable in a subset of CD4-CD8-double negative (DN) 1 thymocytes that express IL-2Rcx (CD25) (2, 3) . However, most rearrangements are out-of-frame at this stage (4) . In contrast, the V-D-J rearrangements of the immediate progeny of these cells (i.e., CD25-DN thymocytes) (3) are predominantly in-frame, indicating that cells within the CD25-DN population have been selected on the basis of productively rearranged [3 chain genes (4) . The CD25 + to CD25-transition is accompanied by a strong cellular proliferation, which is consistent with the fact that CD25-DN thymocytes include a high proportion 1Abbreviations used in this paper: DN, double negative; DP, double positive, pTcx, pre-TCRoq RAG-l, recombinase activating gene 1; RT, reverse transcriptase; SP, single positive.
The first two authors contributed equally to this work. of large cycling cells (5) . Prohferating CD25-blasts rapidly acquire (or express already) low levels of CD4 and CD8 and, therefore, represent cells in transit to the CD4+CD8 + double positive (DP) stage (6, 7) . At this stage, proliferation comes to an abrupt halt, TCRot/[3 is expressed for the first time, and DP thymocytes are subsequently selected to develop into mature CD4 + or CD8 + single positive (SP) thymocytes (5, 8, 9) . Therefore, the transition from CD25 + to CD25-DN thymocytes appears to be the critical stage at which cells with productive [3 chain expression gain a selective advantage to mature further, independently of TCRe~ (3, 4) .
Evidence supporting such a regulatory role of the TCR[3 protein in early T cell development was originally obtained in SCID mice, and later confirmed in rearrangement (RAG-1 or RAG-2)-deficient mice, and in mice with a mutated TCR [3 gene . Both the severe drop in total thymocyte numbers and the blockade at the CD25 + DN stage observed in these animals were fully restored upon introduction of a productively rearranged TCR[3 transgene (9) (10) (11) . Therefore, successful expression of [3, independent of the ot chain, is suflficient for driving CD25 § DN thymocytes to the DP stage, and results in the expansion of the DP thymocyte pool. In contrast, TCR.ot expression appears irrelevant to these processes, but its role seems to be confined to further differentiation ofDP thymocytes to the SP stage (11) .
The biochemical form of the TCRJ3+/e~ -complex involved in early thymocyte development has recently been resolved by the identification on murine pre-T cell lines of a disulphide-linked heterodimer (referred to as pre-TCR) composed of TCRI3 and a novel 33-kD transmembrane glycoprotein termed pre-TCRot (pTot) chain or gp33 (12, 13) . This complex has also been found on large DP thymocytes from TCP,.ot -/-mice (12) . Recent analysis of pTot gene-deficient mice (14) provided formal proof that expression of the pre-TCR is physiologically reqmred for the transition of CD25 § DN T cell precursors, through rapidly dividing CD25-DN cells, into small CD4+CD8 + thymocytes (4, 5, 15) .
Evidence for an equivalent pre-TCR complex in human thymocyte development is still lacking. Furthermore, although TCR[3 rearrangement also precedes that of TCIL0t in humans (16) , no direct experimental evidence has been provided that resolves the timing of TCR [3 and TCl~ot gene expression during the development of human thymocytes. In the present study we have approached this issue by direct examination of the transcriptional activation of both TCRJ3 and TC1kci genes in individual subsets of TCR-negative thymocytes representative of the earliest human intrathymic stages (17) . This analysis allowed us to identify a novel subset of large-sized TClko~/[3-CD4+CD8 + cycling thymocytes that express a functionally rearranged TCRJ3 locus but lack TCRot gene expression. Using eDNA derived from these cells we could identify and clone the human pTot eDNA. Comparison of the developmental regulation of pT0t, TCR[3, TCRel, and RAG-1 gene expression provided a clear picture of the maturauonal progression of early human intrathymic stages and led us to identiff/the transition from CD4+CD8 -to large CD4+CD8 + thymocytes as a key control point in early human T cell development.
Materials and Methods
Cell Samples. Fetal thymus, hver, and bone marrow tassue were obtained from 18-22-wk fetuses after legal termination of pregnancy. Umbilical cord blood samples were collected immediately after delivery. Adult bone marrow was obtained from puncture of the lllac crest of healthy donors. Peripheral blood was obtained from pauents subjected to chemotherapy and treatment with G-CSF. CD34 + cells (>99% punty upon reanalysis) were isolated from the indicated sources by Ficoll-Hypaque (Nycomed, Oslo, Norway) centrifugauon (18) followed by immunomagnetic sorting with anti-CD34-coupled magnetic beads (Dynabeads; Dynal Corp., Oslo, Norway).
Postnatal thymus samples were removed during corrective cardiac surgery of pauents aged 1 mo to 3 yr. Thymocyte suspensions were depleted of small-and medium-sized TCRot/13 + DP thymocytes by centrifugation on stepwlse Percoll (Pharmacla LKB, Uppsala, Sweden) density gradients as previously described (19) . Large thymocytes recovered from the 1.068 density layer were further depleted (>99% purity) of or/J3 and ~//~ mature T cells, as well as of B, NK, and myeloid cells, by two rounds of depletion with anti-CD3-and anti-CD19-coated magnetic beads (Dynal), and with anti-CD56 (Leu-19; Becton Dickinson & Co., San Jose, CA) and anti-CDllb (MO1; Coulter Corp., Hialeah, FL) mAbs indirectly coupled to sheep anti-mouse lgG-coated magnetic beads (Dynal). CD4+CD8 "~ thymocytes were magnetically sorted from the remaining pool with anti-CD8-coated magnetic beads (Dynal). CD4+CD8 -thymocytes were then isolated from the CD8-depleted pool by treatment with ann-CD'4-coated magnetic beads (Dynal). The remaining CD4-CD8-thymocytes were finally sorted into the CD34+CD 1-and CD34+CD 1 + subsets by treatment with an anti-CDla (Nal/34) nLAb (20) indirectly coupled to magnetic beads (Dynal), as described (21) . Mature TCRot/[3 + SP cells were isolated from CDl-depleted large thymocytes by treatment with antl-CD3-coated magnetic beads. Conventional TClko~/J3 + CD4+CD8 § small thymocytes (referred to as DP) were isolated from the 1.09 Percoll density layer by magnetic sorting with anti-CDla. (23) , and labeled with PE-coupied goat anti-mouse IgG1 (Southern Biotechnology Associates, Inc.). Stained cells were analyzed in an Epics XL flow cytometer (Coulter Corp.) as previously described (21) . Cell cycle analyses were performed by flow cytometry in cells treated with 0.05% digatonm, washed, and stained with 50 ~tg/ml of propldmm iodide (both from Sigma Chemical Co.).
Flow
TCR~ Gene Rearrangement Analysis. TCR[3 gene rearrangements were analyzed by using a mo&ficauon of the genomlc DNA-PCR assay described elsewhere (24) . Genomlc DNA (1 p,g) was amphfied by PCR for 30 cycles (1 min at 95~ 2 mm at 68~ and 5 rmn at 72~ in 50 ILl reaction buffer (Perkln-Elmer Cetus, Norwalk, CT.) containing 1.25 U AmphTaq polymerase (Perkin-Elmer Cetus) and 1 ~M each of 5' and 3' primers. The pnmers used to detect D[32 toJI32 rearrangements were as follows: 5'D[32, 5'-GGAGGGGGACTAGCAGGGAGG-3'; and 3'J[3_,, 5'-CACCCAGCTCCTCCAGCTCCGG-3' For V-D-J rearrangements, VJ3-speclfic primers (25) were used in concert with the 3' JI32 primer. PCR products (16 ~zl) were electrophoresed, blotted onto nylon membranes (Zeta Probe, Bio-Rad Laboratones, Hercules, CA), and probed with a 32p-labeled 3'JI32 oligonucleotide (5'-GGCTGGAAGGTGGGGAGACGCCCG-3') located immediately 5' of the 3' Jj3o pnmer used for amphfication.
Northern Blot Analysis. Preparations of total RNA (10 Ixg) isolated as described elsewhere (18) were run on 1% agaroseformaldehyde gels, trasferred to nylon membranes, and hybridized as previously described (26) with 32p-labeled cDNA probes corresponding to the TCR Cot (PY1.4) (27) or C]3 (Jur~2) (28) regions (kindly provided by Dr. T.W. Mak, The Ontario Cancer Institute. Toronto, ON, Canada). The human pT0t cDNA probe was derived in this study (see below). The same blot was subsequently stripped and hybridized with a [3-actin probe (26) .
Reverse Transctiptase-PCR Analysis. Total RNA (1 btg) was reverse transcribed into cDNA according to the manufacturer's protocol (Boehringer Mannheim, Mannheim, Germany). Equivalent amounts of cDNA among different samples was estimated by reverse transcriptase (RT) PCR carried out for 18, 21, and 25 cycles with [3-actin primers, as previously described (18) . Titration of cycle number allowed us to perform densitometric analyses (Bio-imaging BAS 1500; Fujifilm, Kanagawa, Japan) under nonsaturating conditions. The [3-actin control shown in Fig. 4 A also applies to PCR analyses shown in Figs. 4 B, and 5 A. Vot and VJ3 degenerate primers (29) used in combination with either Cot or C[3 primers, respectively, enabled the amplification of all known human Vot and V[3 segments, as described (18, 29) . V[3-specific transcription was assessed by using VI32-, VI36-, and V1313.~-specific primers in concert with a C[3 primer, as previously reported (25) . Specific amplifications were detected by Southern blot hybridization with Cot (27) or C[3 (28) cDNA probes.
Amplifications ofpT0e cDNA were performed for 35 cycles, at an annealing temperature of 55~ using the following primers: 5'pTot, 5'-CCCATCTCTCCCTGCCTTCTG-3'; and 3'pTot, 5'-GGAGCAGGTCAAACAGCAGC-3'. Amplified products were analyzed by Southern blotting with a cDNA pTot probe derived in this study (see below). RAG-1 transcription was assessed by RT-PCR carried out for 30 cycles at an annealing temperature of 55~ followed by Southern blotting using an oligonucleotide probe. As control for the sensitivity of the RAG-1 RT-PCR assay, amplifications were performed simultaneously on serial dilutions of a plasmid vector containing the R.AG-1 full-length cDNA (30) , mixed with a fixed quantity of irrelevant cDNA. Signal intensity was quantitated by densitometric analyses (Bioimaging BAS 1500, Fujiftlm). The following primers were used: 5'RAG-l, 5'-CAGCGTTTTGCTGAGCTCCT-3'; 3'RAG-l, 5'-CTAGGAGAAGCCCTCAATGC-3'; and RAG-1 probe, 5'-AAGTATAGGTATGAGGGAA-3'.
Cloning of the Human p Tee cDNA. cDNA derived from TCRot/ [3-CD4+CD8 + thymocytes was amplified for 40 cycles at an annealing temperature of 50~ by using a combination of primers recognizing sequences in the Ig-like (5'-CCTGGCCTTGAC-AACCCTGTCTG-3') and in the transmembrane (5'-GTG-GTGGCTGGAGGTGCTGGCC-3') domains of the reported mouse pTot cDNA (13) . Amplified products were then fractionated, blotted, and probed with an internal oligonucleotide (5'-GCT-GCAGGTCAGGAGCACATCG-3') specific for the transmembrane domain of the mouse pTot. A 380-bp hybridizing product was purified by standard procedures, cloned in a pMOS Blue-T vector (Amersham International, Amersham, Bucks, UK), and sequenced using a T7 DNA polymerase (Sequenase II, United States Biochemical Corp., Cleveland, OH). Sequence analysis revealed an 82% homology with the corresponding fragment of the murine pTa cDNA. The cloned fragment was then used as a probe for Northern blot and RT-PCR analyses (see above), as well as to probe a cDNA human thymus library (Clontech, Palo Alto, CA.). Three independent positive clones out of 2 • 10 s plated clones were isolated by replating and amplified by PCR using two kgt11 primers flanking the EcoRl cloning site. PCR reactions were carried out for 30 cycles at an annealing temperature of 55~ and amplification products were cloned and sequenced as described above.
Immunoprecipitation and Western Blot. 7 • 107 Cells were lysed in 1 mt of lysis buffer (2% Triton X-100 [Sigma], 20 mM Tris-HCI, pH 7.6, 150 mM NaC1, 1 mM MgCI2, 10 mM iodoacetamide [Merck, Darmstadt, Germany], 1 mM PMSF, and 1 ~g/ml each ofleupeptin, pepstatin, and aprotimn [Sigma Chemical Co.]). After removal of their nuclei, supernatants were precleared three times with normal mouse serum (NMS) Igs coupled to either protein A-or protein G-Sepharose beads (Pharmacia LKB). Immunoprecipitation was carried out overnight with [3F1 (anti-TCR[3) (23) and otF1 (anti-TCR0c) (T Cell Diagnostics, Cambridge, MA) mAbs covalently coupled to either protein G-or protein A-Sepharose beads, respectively, as described (31) . The precipitates were separated by SDS-12% PAGE under nonreducing conditions, and transferred onto nitrocelulose membranes (Bio-Rad Laboratories). Blots were blocked with 5% skim milk TBS, and the TCR~ and TCR0t precipitates were detected by hybridization with either J3F1 ascites diluted 1:2,000 (23), or with 2.5 ~g/ml otF1 mAb, respectively. After three washes with 0.2% Tween-20 (Sigma Chemical Co.) TBS blots were incubated with goat anti-mouse Igs coupled to peroxidase (Amersham International), washed four times, and revealed by the enhanced chemiluminescence method (ECL; Amersham International).
Results

Characterization of a TCR-negative subset of CD4+ CD8 + Large Cycling Human Thymocytes. Recent studies have
shown that the differentiation of the the most immature human T cell precursors, identified as CD34 + DN thymocytes (32), proceeds throughout several TCR-negative stages characterized by the progressive loss of CD34 and the sequential acquisition ofCD1, CD4, and CD8 (32-34). Thus, human T cell precursors acquire CD4 before CD8 (22, 34) as proposed in the following maturation sequence: CD34+CD1-CD4-CD8---) CD34+CD1+CD4-CD8---) CD34+/-CD1 +CD4+CD8 ---) CD34-CD1 +CD4+CD8 +. The latter subset seems to include the immediate progenitors of the major intrathymic subpopulation of small DP thymocytes that express the TCRcl/[3 complex and then differentiate to the SP stage (17) .
To identify the developmental stage at which the successful expression of TCR[3 may be of selective advantage to human thymocytes independent of the TCRot chain, we examined [3 and ot chain gene status in individual subsets of TCRet/[3-early T cell progenitors isolated from the postnatal thymus, according to the proposed maturation sequence (17) . To this end, large thymocytes recovered from Percoll gradients were depleted of mature T, B, NK, and myeloid cells. As shown in Fig. 1 A, expression of CD4 and CD8 defined three different subsets of TCR-negative thymocytes within the remaining pool: CD4-CD8-, CD4+CD8 -, and CD4+CD8 +, representing 9.5 + 4.5%, 29 + 10%, and 60 + 10%, respectively. Immunomagnetic sorting allowed the independent isolation of the three subsets that showed a >99% purity upon reanalysis (Fig. 1 A) set was shown to include relatively large-sized cells, as compared with the subset of conventional TCRot/[3 + DP cortical thymocytes isolated from the Percoll fraction of small cells (Table 1) . As expected (32) , nearly all cells within the CD4-CD8-pool express CD34, whereas CD1 defines two distinct subpopulations of CD34+CD1 + (52.5 + 6%) and CD34+CD1 -(47.5 -+ 6%) thymocytes that were independently isolated (>99% pure) by immunomagnetic sorting (Fig. i B) . Based on the expression ofCD34, CD1, CD4, and CD8 molecules, the four isolated subsets of TCR-negative large-sized thymocytes will be hereafter re- Postnatal thymocytes were fractionated into populations enriched for large or small cells on Percoll density gradients. Subsets of TCRe~/[3 thymocytes and TCR0~/[3 + DP thymocytes were purified either from the large or from the small cell fractions, respectively. Medium-sized cells including both SP and DP TCRoW~3 + thymocytes were not analyzed in this study.
ferred to as CD34+CD1 -, CD34+CD1 +, CD4+CD8 -, and CD4+CD8 +. We next examined in more detail the phenotypic profile displayed by TCRc~/[3-CD4+CD8 + large thymocytes, as compared with that of common cortical TCR~x/[3 + CD4+CD8 + small thymocytes (Fig. 1 C) . It is notable that both subsets coexpressed CDScx and CD813 (Fig. 1 C) and displayed similar expression levels of CD1, CD2, CD4, CD5, and CD7 T-lineage molecules, whereas both lacked expression of CDllb, CD13, CD14, CD16, CD25, CD33, CD56, and CD69 (not shown). However, markers such as CD28, CD44, and CD71 (transferrin receptor), which were weakly expressed on small TCR~/[~ + CD4+CD8 + thymocytes, were consistently found at higher expression levels on large TCRot/[3-CD4+CD8 + thymocytes (Fig. 1 C) . More importantly, both subsets were shown to differ dramatically in their cell cycle status. As shown in Table 1 , the proportion of TCRcx/[3-CD4+CD8 + thymocytes engaged in DNA synthesis and mitosis (up to 45%) was much higher than the proportion of the TCRod[3 + CD4+CD8 + pool (up to 3%), or any other subset of thymocytes (up to 12%). To avoid confusion, conventional TCRot/[3 + CD4+CD8 + small thymocytes will be hereafter referred to as DP thymocytes.
TCRfl Chain Gene Rearrangement during Human Thymocyte Development. Each individual subset of TCR&/~-thymocytes was next examined for the rearrangenient status of their TCR~3 loci by using a PCR genomic assay (24) . As shown schematically in Fig. 2 A, (35) . The resulting P C R products were analyzed by Southern blot hybridization with an internal primer positioned immediately 3' to the J[32 duster (Fig. 2 A) .
Partial rearrangements of D[32 to J[32 were consistently negative in the most early CD34+CD1 -thymocytes, in which a sharp germline band equivalent to that detected in n o n -T (K562) cells was observed (Fig. 2 B) . A conspicuous germline amplification product was also readily detectable in the two downstream subsets o f CD34+CD1 + and C D 4 + C D 8 -thymocytes, indicating that they were essentially in germline configuration. However, very faint bands of rearrangement, particularly those corresponding to short-sized products whose amplification is favored by this technique, were eventually detected in both subsets upon prolonged exposure. In contrast, multiple rearrangements of D [32 to low levels of 1.6-kb germline transcripts could also be detected upon prolonged exposure (not shown). Subsequent hybridization with a Cot probe showed that expression of 1.6-kb mature-length TCRot transcripts only occurred in the DP or SP stages, at which the TCROt/[~ is already expressed on the cell surface (Fig. 3) . Expectedly, mature TCROt and TCR[3 transcripts were present in Jurkat T cells, but not in JY B cells.
To ascertain unambiguously the expression of mature T C R~ message at the C D 4 + C D 8 -stage, as well as to confima the lack of TCRot transcription in both the CD4+CD8 -and the C D 4 + C D 8 + subsets, further studies were performed by using a sensitive R T -P C R technique (18, 29) proved to detect transcription of all known V[3 and Vot T C R genes. As shown in Fig. 4 A, Fig. 4 B. In addition, pan-Vet primers used in combination with Cot primers confirmed the absence of TCR{x transcripts in all thymocyte subsets shown to lack surface TCRet/[3 (Fig. 4 A) . Collectively, our data suggest that, in contrast to mice, the onset of V-D-J TCR[~ gene rearrangement and transcription occurs in humans in immature thymocytes already expressing CD4, and is essentially completed during the transition to the next TCROt/[3-C D 4 + C D 8 + developmental stage.
R A G -I Gene Transcription Is Intrathymically Upregulated during the Transition from the CD34+ CD1 -to the CD34+ CD1 +
Stage. Previous studies in mice have shown that the expression of R A G -1 and R A G -2 genes usefully traces the emergence of T C R gene rearrangement and transcription during T cell development (36) . To approach this issue in humans, R A G -1 transcription was analyzed by R T -P C R in the thymocyte subsets previously examined for their TCRI3 and TCROt gene status (Fig. 5 A) . Comparative (37) . Amino acid sequence analysis was done with the PROSITE pattern database (45) . The nucleotide sequence data of the cloned human pTa cDNA are available from EMBL/GenBank/DDBJ, under accession number U38996. densitometric analyses were performed by using a R A G -1 c D N A titration curve (Fig. 5 B) . As shown in Fig. 5 A, expression of R A G -1 was hardly detected in the most early CD34+CD1 thymocytes, but it increased abruptly (~'-'500-fold) at the next CD34+CD1 + and C D 4 + C D 8 developmental stages. A slightly weaker (about threefold) expression was found in TCRcx/[3-C D 4 + C D 8 + blasts. However, the amount of R A G -1 message increased again (about 20-fold) in the more mature TCRcl/[3 + DP small thymocytes, coincident with the onset of TCRo~ trancription, whereas no message was detected in SP thymocytes (Fig. 5 A) . Because of the high sensitivity o f the R A G -1 P C R assay that allowed us to detect as few as 15 transcripts (Fig. 5 B) , it is very likely that the signal displayed by CD34+CD1 -thymocytes (corresponding to ~<75 R A G - containing a longer cytoplasmic tail (Fig. 6 ). These data were considered reasonable evidence that we had identified the gene encoding the human pT0t chain. In addition, after submission of this manuscript, another group independently cloned a human c D N A (37) with a predicted amino acid sequence essentially identical to that reported here, except for positions 64, 72, 147, and 253 (Fig. 6) .
Next, Northern blot analyses provided evidence that pTot transcription is tightly regulated during human T cell development. As shown in Fig. 3 , we found that the largest amount of pTet transcripts (1.2 kb) corresponded to C D 4 + C D 8 -and C D 4 + C D 8 + TCRot/[3-immature thymocytes. There was a weaker expression in earlier (CD34+CD1 -and CD34+CD1 +) and later (TCRcx/[3 + DP) developmental stages, whereas no pT(x transcription was detected in mature SP thymocytes. These results were confirmed by R T -P C R (not shown).
Expression of murine pTo~ has been reported to be exquisitely T-lineage specific (38) . Accordingly, we could not detect pT~x transcription in human n o n -T cells including B, NK, myeloid, and dendritic cells (not shown). To investigate whether pTol transcription is specifically induced in early pro-T cells after homing to the thymus, expression of pTot m R N A was examined by R T -P C R in highly purified CD34 § hematopoietic progenitors from distinct postnatal and fetal extrathymic tissues. Total thymocytes derived from either fetal (22-wk-old) or adult (1 m o -3 yr) thymus, as well as CD34+CD1 -precursors from adult thymus were included in the study as positive controls. As shown in 7, transcription of pTo~ was easily detected in mobilized CD34 + cells from peripheral blood, as well as in CD34 + precursors isolated from umbilical cord blood or from adult bone marrow. More importantly, pT(x gene expression also occurred in fetal life in CD34 + progenitors present in the liver at 18 wk of gestation, although it was absent in CD34 + precursors from fetal bone marrow at any developmental age up to 22 wk. These results suggest that transcription of the pTcl gene is activated early in ontogeny in CD34 + progenitors, before their entry into the thymus. (Fig. 8 A) . Therefore, nearly all cells at the TCR(x/13-CD4+CD8 + stage have been selected based on productive 13 gene rearrangement.
TCR~8 Chain Is Expressed in CD4 + CD8 + Blasts
To characterize the molecular form of TCR [3 chains involved Fig. 8 B, lf/? ). Strikingly, the anti-TCRe~ mAb failed to immunoprecipitate this TCR[3 complex, or any other protein complex, from C D 4 + C D 8 + thymocyte lysates, whereas an 80-90 kD TCRo~/[~ heterodimer was precipitated from Jurkat T cells with this reagent (Fig. 8 B, right ). Therefore, our data provide evidence that TCRoc/13-C D 4 + C D 8 + blasts express an immature TCR13 complex composed of the TCR[3 chain associated with another chain different from T C R~. Although the molecular mass of this complex fits with that expected for a human pTo~-TCR13 heterodimer, direct evidence for this notion nmst still await the development of suitable reagents against the human pTot chain.
Discussion
In this study, we have tried to identify the critical stages in early human intrathymic differentiation where most of the developmental decisions are made. In particular, we have focussed on the developmental point at which TCRI3 may confer on intrathymic precursors a selective advantage to mature further in the absence of TCRcx expression. These studies have been greatly facilitated by the observation that the DN to DP transition occurs in humans through a CD4+CD8 -intermediate (32) (33) (34) . Our results show that it is precisely at this CD4+CD8 -developmental (Fig. 9 ) that envisages the CD4+CD8 -to CD4+CD8 + transition as the critical point at which human thymocytes are selected based on productive TCR[3 expression. According to this model, the onset ofV-D-J TCR[3 gene rearrangement and transcription occurs relatively late in human thymocyte development, as CD34+CD1 + pro-T cells downregulate CD34 and acquire the CD4 coreceptor molecule, and it is preceded by activation of the recombinase machinery (i.e., transcription of RAG-l) during the CD34+CD1 -to CD34+CD1 + transition. These results seem in conflict with those recently reported by Ktorza et al. (41) showing RAG-1 and mature TCR[3 transcription at earlier intrathymic stages. However, no quantitative analyses were reported in that study to rule out the possibility that amplified transcripts do correspond to downstream cell contaminants.
The proposal that productive TCR[3 expression occurs at the CD4+CD8 -to CD4+CD8 + transition is further supported by our observation that TCRc~/~-CD4+CD8 + thymocytes include a high proportion of cycling cells, an expected, finding considering that functional expression of TCR[3 results in clonal expansion ofmurine thymocytes at the equivalent developmental point (5, 7, 8) . Based on what is already known in the mouse about the implication of the pToL-TCR[3 complex in this maturation step, we performed experiments designed to provide evidence for the existence of an equivalent complex in humans. We identified and cloned a human cDNA highly homologous to the murine pTci (13) , with a predicted anfino acid sequence that is essentially identical to that recently reported by others as the human pTcl chain (37) . As described in mice (13) , pTcx gene expression was also shown to be de- velopmentally regulated in humans. We found that pTor message is highly expressed by both the CD4+CD8 -and the CD4+CD8 + TCRod[3-thymocyte subsets, whereas there is a weaker expression in earlier and later stages of development. The coincident expression of TCR[3 protein and pTo~ transcripts (in the absence of TCRor y, and 8 proteins) in TCRod[3-CD4+CD8 + blasts, strongly suggests that cells in transit to this stage monitor the occurrence of productive TCR[3 rearrangements through a human pTcI-TCR[3 heterodimer. Supporting this possibility, a TCR[3 complex of the expected size, and different from the mature TCR~x/[3 heterodimer, was immunoprecipitated from TCRod[3-CD4+CD8 + blasts. However, we have been unable as yet to biochemically resolve this putative pTot-TCR[3 heterodimer in reducing gels, probably because the pTo~ chain escapes detection by current labeling techniques, as reported in mice (12) . Though pTci protein expression studies still await the development of suitable anti-pTix reagents, the results reported here allow us to propose that the earliest direct action of the putative human pre-TCR is to induce rapid clonal expansion, and simultaneous transition ofthymocytes from the CD4+CD8 -to the CD4+CD8 + stage. Analysis on the developmental expression of the human pTcl gene provided evidence that pToL is also expressed outside the thymus in CD34 + progenitors isolated from distinct adult hematopoietic tissues. More importantly, pTix transcription was also detected early in fetal life in CD34 + precursors present in the liver, whereas no pTix expression was found in fetal bone marrow CD34 + ceils. Although the precursor potential of the latter CD34 + subset needs to be analyzed before further conclusions can be drawn, the fact that CD34 + fetal liver cells do contain TCIko~/[3 precursor potential (17, 18) may suggest that there is a coincidence of pTot expression and precursor activity for TCP,.(x/~ T cells in hematopoietic precursors before their entry into the thymus. Alternatively, pTot-expressing extrathymic CD34 + cells may represent recirculating pro-T cells derived from the thymus. This possibility appears very unlikely considering that pTot gene expression has also been found in the bone marrow of athymic mice (38) . Finally, we provide evidence that pT(x IkNA is expressed by the most immature CD34+CD1 -thymocytes that still have the potential to develop into TCR~//8, dendritic, myeloid, and NK cells (17, 21) . Therefore, pTot transcription precedes the onset of TCP,[3 rearrangement and IkAG-1 expression inside the thymus. An intriguing feature of these early intrathynfic precursors, also found in their murine counterparts (2, 42) , is that they express 1.0-and 1.6-kb germline TCP,,13 transcripts before the onset of D-J TCR~ rearrangement (our present study). It is believed that TCR gene segments are selectively rendered accessible to the recombinase machinery by developmentally regulated transcription while they are still in their germline configuration (43) . Whether the coincident expression of pT(x and germline TC1M3 transcripts identifies TCIt.ot/lBcommitted precursors within the CD34+CD1 -immature pool of thymocytes deserves further investigation. However, given that both the onset of full-length TCR.[3 transcription and the upregulation of pTot gene expression are downstream events coincident with the acquisition of surface CD4, we favor the view that the CD4+CD8 -stage represents the critical point at which intrathymic precursors restrict their developmental potential towards the TCR(x/[3 lineage.
